| Unadjusted OR (95 % CI) | Unadjusted p-value | Adjusted OR (95 % CI) | Adjusted p-value |
---|---|---|---|---|
Age (per 1 year increase) | 0.97 (0.93–1.01) | 0.16 | 0.98 (0.94–1.05) | 0.48 |
Male gender | 0.72 (0.38–1.35) | 0.31 | 0.80 (0.39–1.63) | 0.54 |
Lymph node involvement at initial TB diagnosis | 2.36 (1.18–4.76) | 0.02 | 1.79 (0.81–3.98) | 0.15 |
Drug-resistant TBa | 4.13 (1.32–15.56) | 0.02 | 3.26 (0.97–12.99) | 0.07 |
Hospitalised at time of TB-IRIS diagnosis | 0.40 (0.22–0.75) | 0.004 | 0.5 (0.25–0.99) | 0.05 |
TB-IRIS lymph node involvement | 3.01 (1.63–5.65) | 0.0005 | 2.27 (1.13–4.59) | 0.02 |
TB-IRIS pulmonary involvement | 0.54 (0.29–1.02) | 0.06 | 0.65 (0.32–1.30) | 0.23 |
Cohort 2b | 0.06 (0.01–0.18) | < 0.0001 | Not included |  |
Cohort 1b | 0.29 (0.12–0.62) | 0.002 | Not included |  |